SCHEMBL4902601

SCHEMBL4902601

CCN(Sc1ccc(Oc2ccc(C)c(C)c2)cc1)S(=O)(=O)c1cc(C)c(C)c(C(=O)OC)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
TSHR P16473 2/20 0.38
CYP2C9 P11712 1/20 0.34
LMNA P02545 4/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
HTT P42858 1/20 0.33
MAPT P10636 6/20 0.33
KDM4E B2RXH2 2/20 0.33
HSD17B10 Q99714 1/20 0.33
HPGD P15428 3/20 0.33
GAA P10253 2/20 0.33
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C19 P33261 1/20 0.32
PKM P14618 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
MMP1 P03956 1/20 0.32
MMP9 P14780 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4904210 0.92 KDM4E (0.40) ALDH1A1TSHRCYP2C9LMNASMN1; SMN2
SCHEMBL4902983 0.92 ALDH1A1 (0.39) ALDH1A1TSHRCYP2C9LMNASMN1; SMN2
SCHEMBL5930735 0.92 TSHR (0.36) ALDH1A1TSHRLMNASMN1; SMN2NPC1
SCHEMBL4904426 0.91 TDP1 (0.36) CYP2C9LMNASMN1; SMN2NPC1RAB9A
SCHEMBL4895549 0.91 ALDH1A1 (0.39) ALDH1A1TSHRCYP2C9LMNASMN1; SMN2
SCHEMBL4905600 0.90 ALDH1A1 (0.38) ALDH1A1TSHRLMNASMN1; SMN2NPC1
SCHEMBL4905798 0.90 ALDH1A1 (0.44) ALDH1A1TSHRCYP2C9LMNASMN1; SMN2
SCHEMBL4902777 0.90 PLA2G7 (0.38) ALDH1A1TSHRLMNAHTTMAPT
SCHEMBL4899783 0.89 ALDH1A1 (0.40) ALDH1A1TSHRLMNASMN1; SMN2KDM4E
SCHEMBL4906211 0.89 TSHR (0.41) ALDH1A1TSHRCYP2C9LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD ALDH1A1 2664/4885TSHR 412/4885CYP2C9 3366/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD ALDH1A1 2956/4885TSHR 400/4885CYP2C9 3557/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD ALDH1A1 2956/4885TSHR 400/4885CYP2C9 3557/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.